Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 A comparison of general clinical data and biochemical markers between groups with good and poor prognosis

From: Prognostic significance of free triiodothyronine levels in alpine region patients undergoing drug-coated balloon therapy for coronary heart disease

Observational indicator

Good prognosis group (n = 151)

Poor prognosis group (n = 40)

t/X2

P

Age (years, mean ± s)

59 ± 9.7

65 ± 14

-2.483

0.017

Gender [n (%)]

  

0.624

0.430

Male

103(68.2%)

24(60.0%)

  

Female

48(31.8%)

16 (40.0%)

  

History of high blood pressure [n (%)]

111(73.5%)

34(85.0%)

1.698

0.193

History of diabetes [n (%)]

55(36.4%)

21(52.5%)

2.773

0.096

Previous coronary intervention [n (%)]

45(29.8%)

21(52.5%)

6.236

0.013

Previous myocardial infarction [n (%)]

30(19.9%)

10(25.0%)

0.241

0.624

Smoking history [n (%)]

98(64.9%)

23(57.5%)

0.461

0.497

Diagnosis [n (%)]

  

7.063

0.070

Acute non-ST elevation myocardial infarction

22(14.6%)

7(17.5%)

  

Acute ST elevation myocardial infarction

30(19.9%)

1(2.5%)

  

Stable angina

20(13.2%)

7(17.5%)

  

Unstable angina

79(52.3%)

25(62.5%)

  

TSH (uIU/ml, mean ± s)

2.8 ± 2.6

5.3 ± 15

− 1.053

0.299

FT3(pmol/L, mean ± s)

4.4 ± 0.72

4. 1 ± 0.90

2.013

0.049

FT4(pmol/L, mean ± s)

16 ± 2.5

15 ± 3.0

0.540

0.592

Platelet count (× 109/L, mean ± s)

210 ± 52

220 ± 70

-0.646

0.521

Fibrinogen (g/L, mean ± s)

3. 1 ± 0.90

3.2 ± 0.70

-0.721

0.473

Uric acid (µmol/L, mean ± s)

340 ± 85

330 ± 91

0.290

0.773

Triglycerides (mmol/L, mean ± s)

1.9 ± 1.2

1.8 ± 0.78

1.007

0.317

Total cholesterol (mmol/L, mean ± s)

4. 1 ± 1. 1

4. 1 ± 1.3

0.040

0.969

High-density lipoprotein (mmol/L, mean ± s)

1.0 ± 0.29

1.0 ± 0.20

-0.458

0.648

Low-density lipoprotein (mmol/L, mean ± s)

2.5 ± 0.95

2.5 ± 0.97

0.329

0.743

Cardiac injury markers (ng/L, mean ± s)

320 ± 810

200 ± 360

1.314

0.191

N-terminal pro b-type natriuretic peptide (pg/ml, mean ± s)

330 ± 570

900 ± 1400

-2.476

0.017

Homocysteine (µmol/L, mean ± s)

16 ± 10

16 ± 8.0

0.067

0.947

Glycated hemoglobin (%, mean ± s)

2.9 ± 4.0

3.9 ± 3.7

− 1.468

0.147

Ejection fraction (%, mean ± s)

62 ± 7.4

61 ± 7.8

0.743

0.460

Gensini score (mean ± s)

40 ± 25

44 ± 22

-0.986

0.032